Zacks.com Featured Highlights Include: Cardinal Health, Anixter International, Abercrombie & Fitch, Brookdale Senior Living And Fluor

 | Feb 25, 2020 08:21PM ET

For Immediate Release

Chicago, IL – February 26, 2020 – Stocks in this week’s article are Cardinal Health (NYSE:CAH) , Anixter International (NYSE:AXE) , Abercrombie & Fitch (NYSE:ANF) , Brookdale Senior Living (NYSE:BKD) and Fluor Corp. (NYSE:FLR) .

5 Broker-Friendly Stocks to Ride Out the Coronavirus Scare

Equity markets are persistently rattled by the outbreak of the deadly coronavirus, which has claimed multiple lives so far. What is worse is that the virus, which was hitherto mostly restricted within China, has been spreading its tentacles to other countries like South Korea and Italy. The United States is also not immune to this latest health hazard with new cases being registered recently.

The impact of the coronavirus on markets is feared to be more damaging than the SARS outbreak in March 2003. Due to coronavirus-related woes, many companies issued bearish outlooks for the ongoing quarter or even the full year. In fact, travel-focused stocks are very badly hit. The International Air Transport Association expects airline revenues for 2020 to be hurt in excess of $29 billion due to this adversity.

However, the sole aim of investors while designing their portfolio is to generate handsome returns irrespective of the prevalent situation. They, after all, are putting their hard-earned money in stocks. One of the well-accepted investment strategies is to maintain a diversified portfolio to generate substantial returns irrespective of the market conditions.

Amid the extant confusion, it is almost impossible for individual investors to come up with a winning portfolio of stocks without proper guidance. Therefore, it is in the best interest of investors to seek advice from “experts in the field."

Who Are the Experts & Why?

The above write-up clearly suggests that by following broker actions, one can arrive at a winning portfolio of stocks. Keeping this in mind, we designed a screen to shortlist stocks based on improving analyst recommendation and upward revisions in earnings estimates over the past four weeks. Also, since the price/sales ratio is a strong complementary valuation metric in the presence of analyst information, it has been included. The price/sales ratio takes care of the company’s top line, making the strategy effective.

For the rest of this Screen of the Week article please visit Zacks.com at:Zacks Investment Research

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes